[01]
Innovation partners
[02]
Institutional research
[03]
Orbital infrastrucutre
Space as extension
We envision a future where space becomes an essential extension of the pharmaceutical and biotech ecosystem — a place where the unique conditions of microgravity become a recurring tool in the discovery, design, and manufacture of advanced therapies.
Microgravity as catalyst
Microgravity will unlock new scientific insights, enable cleaner and more precise biomanufacturing processes, and accelerate the development of next-generation medicines — biologics, regenerative therapies, and targeted compounds we cannot fully realize on Earth.
An open value chain
We see orbital infrastructure as part of a single open value chain, governed by shared standards. Our role is to convene actors — across pharma, space, regulation, and capital — that would otherwise design in isolation.
Scientific rigor
Every claim, payload and protocol is published, peer-reviewed where possible, and held to the same evidentiary standard as terrestrial pharmaceutical research.